You are here:
Select the mission or strategic goal page to track progress against its targets for the 2011-15 strategy:
International Finance Facility for Immunisation evaluation
Gavi second evaluation report
Gavi first evaluation report
From its inception in 2000 to September 30 2014, Gavi has disbursed over US$7 billion to over 70 countries.
View which countries have been approved for each type of Gavi support.
The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership.
Download the PDF version of the 2013 report
Explore the online version of the 2013 report
Over the course of a decade, the weighted average price of pentavalent vaccine (DTP-hepB-Hib) dropped by 43% from US$ 3.56 per dose in 2003 to US$ 2.04 per dose in 2013, with a lowest-ever price of US$ 1.19 from one supplier in 2013.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2014
modal window here